ACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 1-Year Low at $14 60 kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. The average twelve-month […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 12,030,000 shares, an increase of 7.8% from the April 15th total of 11,160,000 shares. Based on an average trading volume of 1,810,000 shares, the short-interest ratio […]
Brokers Issue Forecasts for ACADIA Pharmaceuticals Inc s FY2026 Earnings (NASDAQ:ACAD) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Leerink Partnrs Research Analysts Increase Earnings Estimates for ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.